Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Butler

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Cancer Genetics and Cytogenetics|January 1, 1987
Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma?F Cabanillas, S Pathak, A Zander, et al.
American Journal of Clinical Oncology|December 1, 1984
Stages I and II non-Hodgkin's lymphomas of Waldeyer's ring and the neckJ S Kong, L M Fuller, J J Butler, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Blood|May 1, 1985
Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometryJ Srigley, B Barlogie, J J Butler, et al.
Cancer|December 1, 1982
Treatment of patients with stages I and II nonmediastinal Hodgkin's diseaseF B Hagemeister, L M Fuller, J A Sullivan, et al.
Cancer Treatment Reports|September 1, 1977
Team approach to management of non-Hodgkin's lymphomas: past and presentL M Fuller, J F Gamble, J J Butler, et al.
The American Journal of Medicine|August 1, 1989
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphomaF Cabanillas, S Pathak, G Grant, et al.
Cancer Treatment Reports|April 1, 1982
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPPF B Hagemeister, L M Fuller, W S Velasquez, et al.
American Journal of Hematology|March 1, 1990
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W S Velasquez, J J Butler, et al.
Radiology|December 1, 1981
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomyF B Hagemeister, L M Fuller, J A Sullivan, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Cancer Genetics and Cytogenetics|January 1, 1987
Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma?F Cabanillas, S Pathak, A Zander, et al.
American Journal of Clinical Oncology|December 1, 1984
Stages I and II non-Hodgkin's lymphomas of Waldeyer's ring and the neckJ S Kong, L M Fuller, J J Butler, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Blood|May 1, 1985
Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometryJ Srigley, B Barlogie, J J Butler, et al.
Cancer|December 1, 1982
Treatment of patients with stages I and II nonmediastinal Hodgkin's diseaseF B Hagemeister, L M Fuller, J A Sullivan, et al.
Cancer Treatment Reports|September 1, 1977
Team approach to management of non-Hodgkin's lymphomas: past and presentL M Fuller, J F Gamble, J J Butler, et al.
The American Journal of Medicine|August 1, 1989
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphomaF Cabanillas, S Pathak, G Grant, et al.
Cancer Treatment Reports|April 1, 1982
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPPF B Hagemeister, L M Fuller, W S Velasquez, et al.
American Journal of Hematology|March 1, 1990
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W S Velasquez, J J Butler, et al.
Radiology|December 1, 1981
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomyF B Hagemeister, L M Fuller, J A Sullivan, et al.
Pageof 13